Final Demonstration of the Co-Identity of Lipiarmycin A3 and Tiacumicin B (Fidaxomicin) through Single Crystal X-ray Analysis
Serra, S.; Malpezzi, L.; Bedeschi, A.; Fuganti, C.; Fonte, P. Final Demonstration of the Co-Identity of Lipiarmycin A3 and Tiacumicin B (Fidaxomicin) through Single Crystal X-ray Analysis. Antibiotics 2017, 6, 7. https://0-doi-org.brum.beds.ac.uk/10.3390/antibiotics6010007
Serra S, Malpezzi L, Bedeschi A, Fuganti C, Fonte P. Final Demonstration of the Co-Identity of Lipiarmycin A3 and Tiacumicin B (Fidaxomicin) through Single Crystal X-ray Analysis. Antibiotics. 2017; 6(1):7. https://0-doi-org.brum.beds.ac.uk/10.3390/antibiotics6010007
Chicago/Turabian StyleSerra, Stefano, Luciana Malpezzi, Angelo Bedeschi, Claudio Fuganti, and Piera Fonte. 2017. "Final Demonstration of the Co-Identity of Lipiarmycin A3 and Tiacumicin B (Fidaxomicin) through Single Crystal X-ray Analysis" Antibiotics 6, no. 1: 7. https://0-doi-org.brum.beds.ac.uk/10.3390/antibiotics6010007